Francis Braun

Director/Board Member at SHF HOLDINGS, INC.

Net worth: 154 077 $ as of 2026-06-29

65 year

38 connections

Commercial Services

Consumer Services

Finance

Profile

Francis A. Braun is currently Director at Polaryx Therapeutics, Inc. since 2026, Director at Crown Bank since 2024, Independent Director at SHF Holdings, Inc. since 2025, and Independent Director at ITG, Inc. since 2026.
Former roles include Independent Director at Elite Express Holding, Inc. in 2025 and Partner at Grant Thornton LLP from 2016 to 2023.
Education includes an undergraduate degree from Rider University, conferred in 1983.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
0.02%	2026-07-01	8,700 ( 0.02% )	154 077 $	2026-06-29
SHF HOLDINGS INC CLASS A -.--%	2026-04-29	0 ( -.--% )	- $	2026-06-29

Francis Braun active positions

Companies	Position	Start
SHF HOLDINGS, INC.	Director/Board Member	2025-05-01
POLARYX THERAPEUTICS, INC.	Director/Board Member	2026-01-28

All active positions of Francis Braun

Former positions of Francis Braun

Companies	Position	End
Grant Thornton LLP Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting, assurance, tax and advisory services	Corporate Officer/Principal	2023-06-30

See the detail of Francis Braun's experience

Training of Francis Braun

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Francis Braun's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Grant Thornton LLP Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting, assurance, tax and advisory services	Commercial Services
Rider University Rider University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Polaryx Therapeutics, Inc. Polaryx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that engages in discovery, development and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders	Commercial Services
SHF Holdings, Inc. SHF Holdings, Inc. Financial ConglomeratesFinance Provides financial services for cannabis industry	Finance